4.6 Article

The impact of cathodal tDCS on the GABAergic system in the epileptogenic zone: A multimodal imaging study

Journal

FRONTIERS IN NEUROLOGY
Volume 13, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fneur.2022.935029

Keywords

GABA; pharmacoresistant epilepsy; tDCS; MRS; epileptiform interictal discharges

Funding

  1. Fundacao Luso-Americana para o Desenvolvimento [Premio FLAD Life Sciences 2020]
  2. Portuguese Foundation for Science and Technology (FCT), COMPETE [DSAIPA/DS/0041/2020, FCT-UID/04950 BP/2020]
  3. Centro 2020 FEDER [CENTRO-01-0145-FEDER-000016]
  4. COMPETE
  5. PAC-MEDPERSYST [POCI-01-0145- FEDER-016428]
  6. AIMS-2-Trials
  7. NIH [R01 EB016089, R01 EB023963, P41 EB031771]

Ask authors/readers for more resources

This study investigated the antiepileptic effects of cathodal transcranial direct current stimulation (c-tDCS) and its mechanisms of action on neurotransmitters and brain metabolites. The results showed that real c-tDCS decreased the number of epileptiform discharges and reduced GABA concentration in the epileptogenic zone. These findings provide insights into the mechanisms of action of tDCS for epilepsy treatment.
Objectives: We aimed to investigate the antiepileptic effects of cathodal transcranial direct current stimulation (c-tDCS) and mechanisms of action based on its effects on the neurotransmitters responsible for the abnormal synchrony patterns seen in pharmacoresistant epilepsy. This is the first study to test the impact of neurostimulation on epileptiform interictal discharges (IEDs) and to measure brain metabolites in the epileptogenic zone (EZ) and control regions simultaneously in patients with pharmacoresistant epilepsy. Methods: This is a hypothesis-driven pilot prospective single-blinded repeated measure design study in patients diagnosed with pharmacoresistant epilepsy of temporal lobe onset. We included seven patients who underwent two sessions of c-tDCS (sham followed by real). The real tDCS session was 20 min in duration and had a current intensity of 1.5 mA delivered via two surface electrodes that had dimensions of 3 x 4 cm. The cathode electrode was placed at FT7 in the center whereas the anode at Oz in the center. After each session, we performed electroencephalographic recording to count epileptiform IEDs over 30 min. We also performed magnetic resonance spectroscopy (MRS) to measure brain metabolite concentrations in the two areas of interest (EZ and occipital region), namely, gamma-aminobutyric acid (GABA), glutamate (Glx), and glutathione. We focused on a homogenous sample where the EZ and antiepileptic medications are shared among patients. Results: Real tDCS decreased the number of epileptiform IEDs per min (from 9.46 2.68 after sham tDCS to 5.37 +/- 3.38 after real tDCS), p = 0.018, as compared to sham tDCS. GABA was decreased in the EZ after real c-tDCS stimulation as compared to sham tDCS (from 0.129 +/- 0.019 to 0.096 +/- 0.018, p = 0.02). The reduction in EZ GABA correlated with the reduction in the frequency of epileptiform IED per min (rho: 0.9, p = 0.003). Conclusion: These results provide a window into the antiepileptic mechanisms of action of tDCS, based on local and remote changes in GABA and neural oscillatory patterning responsible for the generation of interictal epileptiform discharges.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available